Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age16+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

The primary goal of this observational study is to learn about postpartum pulmonary artery pressure in women who suffered from Preeclampsia and Antiphospholipid Syndrome.

The main question it aims to answer is whether the conjunction of preeclampsia with obstetric antiphospholipid syndrome significantly foster the development of long-lasting pulmonary hypertension.

Only participants who suffered from preeclampsia during pregnancy will be followed for a period up to 3 years postpartum. Researchers will compare women with or without obstetric antiphospholipid syndrome.

Eligibility criteria

Qualifiers

Age: > 16 years.

Consent or waiver of consent according Chapter 9

Preeclampsia

Proteinuria (urine protein >300mg /24h or 2+ or higher in dipstick on multiple occasions)

Disqualifiers

Age: < 16 years

Incomplete or ambiguous data: if data confirming the eligibility criteria or data to analyze the primary endpoint is not fully available or despite efforts assessed as significantly ambiguous, the data set will be excluded from analyses, since no analysis is possible

Trial design

Treatments tested in this trial

  • Echocardiography images
  • 24-hour ambulatory blood pressure monitoring

Treatment groups

900 Participants
are divided into 2 treatment groups